Neuromyelitis optica (NMO)

View Details
logo
Parent item
  • Aka: Devic’s disease
    • Is monophasic or relapsing-remitting demyelinating CNS disorder
    • Although previously thought to be a variant of multiple sclerosis, it is now recognized to be a distinct disease, particularly prevalent in Asian populations.
  • Features of optic neuritis include unilateral decrease in visual acuity over, poor discrimination of colors, “red desaturation,” pain worse on eye movement, relative afferent pupillary defect and a central scotoma.
  • Diagnostic criteria
    • Bilateral optic neuritis
    • Transverse myelitis
    • 2 of the following
      • Spinal cord lesion involving three or more spinal levels (longitudinally extensive transverse myelitis)
      • Initially normal MRI brain
      • Aquaporin 4 positive serum antibody (positive in 80%)
  • Adults are especially likely to develop a pattern more typical of relapsing-remitting MS after an initial episode of neuromyelitis optica.
  • Treatment
    • Prednisolone
    • Plasma exchange
    • Recovery from acute optic neuritis usually takes 4-6 weeks.
    • Long term treatment is with immunosuppression (e.g. azothiaprine, rituximab).
    • Disease modifying drugs used in MS are not used in the treatment of NMO